Testing the Druggable Endothelial Differentiation Gene 2 Knee Osteoarthritis Genetic Factor for Replication in a Wide Range of Sample Collections

R. Dieguez-Gonzalez,M. Calaza,D. Shi,I. Meulenbelt,J. Loughlin,A. Tsezou,J. Dai,K. N. Malizos,E. P. Slagboom,M. Kloppenburg,K. Chapman,Q. Jiang,D. Kremer,J. J. Gomez-Reino,N. Nakajima,S. Ikegawa,A. Gonzalez

DOI: https://doi.org/10.1136/ard.2008.093641

IF: 27.973

2008-01-01

Annals of the Rheumatic Diseases

Abstract:Objectives: To replicate a previously reported association with osteoarthritis (OA) of the promoter single nucleotide polymorphism (SNP) rs10980705 in the endothelial differentiation gene 2 (EDG2).Methods: Five collections of samples, four from Europe and one from China, were studied. They included patients with 3 OA phenotypes: 1501 with knee OA, 1497 with hip OA and 376 with generalised OA. A total of 2521 controls were also studied. Allele and genotype frequencies of the rs10980705 SNP were analysed in each individual sample collection and in pooled data. In addition, a meta-analysis to incorporate results from the original Japanese report was performed.Results: The association of the rs10980705 SNP with knee OA was not replicated in any of the five sample collections studied or in their combined analysis (odds ratio (OR) 1.10, 95% CI 0.98 to 1.22; p = 0.10). Meta-analysis of all data, including the original Japanese study, did show association with knee OA (OR 1.15, 95% CI 1.06 to 1.26; p = 0.002) but the effect was accounted for by the Japanese data and was less significant than the original report. No association was found with hip OA or with generalised OA.Conclusions: The original report of a promising genetic association between a druggable G-protein coupled receptor, EDG2, and knee OA has not been replicated. This lack of replication could be due to a modest effect of the promoter polymorphism that will require even larger studies (the winners curse) although a more pronounced effect in the Asian population vs Europeans cannot be excluded.